Showing results (51-60 of 115) with videos related to
Sort By:
Pageof 12
Cold Spring Harbor Perspectives in Medicine|September 20, 2015
EpileptogenesisAsla Pitkänen, Katarzyna Lukasiuk, F Edward Dudek, et al.Epilepsia|September 28, 2022
Lacosamide decreases neonatal seizures without increasing apoptosisRachel L Langton, Shaunik Sharma, Grant C Tiarks, et al.Journal of Neurophysiology|March 9, 2007
Desynchronization of glutamate release prolongs synchronous CA3 network activityJethro Jones, Elizabeth A Stubblefield, Timothy A Benke, et al.Neuroscience Letters|April 29, 2006
Kynurenic acid has a dual action on AMPA receptor responsesChristina Prescott, Autumn M Weeks, Kevin J Staley, et al.Acta Neuropathologica Communications|October 7, 2025
Dendritic beading during early brain development impairs signal transmission and synaptic plasticityPratyush Suryavanshi, Satya Murthy Tadinada, Samuel Baule, et al.Nature Neuroscience|December 13, 2006
A new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanolJoseph Glykys, Zechun Peng, Dev Chandra, et al.Neurobiology of Disease|January 27, 2023
Role of NKCC1 and KCC2 during hypoxia-induced neuronal swelling in the neonatal neocortexYusuke Takezawa, Rachel Langton, Samuel M Baule, et al.Epilepsia Open|October 19, 2021
The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy modelsMorgan L Sturgeon, Rachel Langton, Shaunik Sharma, et al.Journal of Child Neurology|May 2, 2009
Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1Kristopher T Kahle, Sarah M Barnett, Kenneth C Sassower, et al.Epilepsia|July 13, 2010
The effect of the cannabinoid-receptor antagonist, SR141716, on the early stage of kainate-induced epileptogenesis in the adult ratF Edward Dudek, Wendy A Pouliot, Christina A Rossi, et al.Pageof 12